Abstract：【Objective】To explore the clinical efficacy of budesonide combined with spleen aminopeptide in the treatment of children with asthmatic bronchitis. 【Methods】A total of 80 children with asthmatic bronchitis admitted to our hospital from January 2020 to May 2022 were selected and grouped by the ball-touching method. Those with odd numbers were assigned to the control group (n=40), and those with even numbers to the observation group (n=40). The control group was given conventional treatment combined with budesonide atomization inhalation, while the observation group was given additional spleen aminopeptide treatment on the basis of the control group. The clinical efficacy, pulmonary function indexes [forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), maximum voluntary ventilation (MVV)] before and after treatment, immune function indexes (CD3+, CD4+, CD8+, CD4+/CD8+), and serum inflammatory factor [interleukin-4 (IL-4), interleukin-8 (IL-8), tumor necrosis factor (TNF-α), monocyte chemoattractant protein-1 (MCP-1)] levels were compared between the two groups. 【Results】After treatment, the total effective rate of the observation group was higher than that of the control group (P<0.05); the levels of FEV1, FVC, MVV, CD3+, CD4+, and CD4+/CD8+ in the observation group were higher than those in the control group (P<0.05), while CD8+ was lower than that in the control group (P<0.05); the levels of IL-4, IL-8, TNF-α, and MCP-1 in the observation group were lower than those in the control group (P<0.05).【Conclusion】Budesonide combined with spleen aminopeptide in the treatment of children with asthmatic bronchitis can significantly improve the clinical therapeutic effect, enhance pulmonary function and immune function, and reduce the levels of serum inflammatory factors.
徐青亮, 陈旋, 陈琦. 布地奈德联合脾氨肽治疗喘息性支气管炎患儿的临床疗效[J]. 医学临床研究, 2025, 42(10): 1736-1738.
XU Qingliang, CHEN Xuan, CHEN Qi. Clinical Efficacy of Budesonide Combined with Spleen Aminopeptide in the Treatment of Children with Asthmatic Bronchitis. JOURNAL OF CLINICAL RESEARCH, 2025, 42(10): 1736-1738.
2025, Vol. 42 
